血清转换 serum conversion(7) hbeag seroconversion(70) serological conversion(0)   serum conversion      After 52 weeks, the HBeAg serum conversion rate of LAM + Tα1 group was 58. 1 % , and that of the LAM group was 21.9%. Comparing the results of the two groups, the difference was remarkable.      治疗52周时Tα1+LAM组乙型肝炎e抗原(HBeAg)血清转换率为58.1%,LAM组为21.9%, 两组比较差异有显著性。 短句来源      【Results】After lamivudine treatment,HBeAg negative rate was 40.38%,eAg/ anti-e serum conversion rate was 28.85%,the HBV DNA negative rate was 74.14%,the ALT recovery rate was 77.59%.      【结果】3TC治疗HBeAg阴转率为40.38%,eAg/抗-e血清转换率为28.85%,HBVDNA阴转率为74.14%,ALT复常率为77.59%。 短句来源      The serum conversion rate of HBeAg/anti-HBe in the treated group is 58.6%.      治疗组HBeAg/抗 -HBe血清转换率达 5 8.6 %。 短句来源      Methods:By genetic recombinant technique,have constructed 2 eukaryotic expressing plasmids namely pS2.S and pFP,encoding HBV envelope middle protein(preS2+HBsAg) and human leukocyte cytokines fusion protein(IL 2/IFN γ) genes respectively and evaluated its efficacy for inducing cellular immunity in healthy BALB/c mice and HBsAg serum conversion in HBV transgenic(Tg) mice after immunization of the plasmids by intramuscular administration.      方法 :应用基因重组技术 ,构建编码HBV中蛋白 (preS2 +S)及人白细胞介素融合蛋白基因的真核表达质粒pS2 .S及pFP ,继经肌注免疫健康Balb C及HBV转基因 (Tg)小鼠并观察健康小鼠细胞免疫应答及HBVTg小鼠HBsAg的血清转换。 短句来源      Results: No significant difference was observed in liver function improvement between two groups (P>0.05). The treatment group achieved better results than contrast group in HBeAg serum conversion, HBV-DNA to negative and hepatic fibrosis indices (P<0.05).      结果:两组肝功能改善无显著性差异(P>0.05),治疗组在HBeAg血清转换、HBV-DNA转阴、肝纤维化指标好转等几方面均明显优于对照组(P<0.05)。 短句来源 更多          hbeag seroconversion      Results Those ALT>3×ULN,HBV DNA<4.2×10~6 copies/ml before the treatment,and with virus response at an early stage have a high HBeAg seroconversion(P <0.01 or <0.05).      结果治疗前ALT≥3×ULN,HBV DNA<4.2×106拷贝/ml,出现早期病毒学应答者HBeAg血清转换率较高(P<0.01或<0.05)。 短句来源      Lamivudine (25 mg/d) could effectively clear HBV DNA [97.7% vs. 22.2%, RR 4.41, 95%CI (2.86,6.79)] and improve histology response [59.3% vs. 30%, RR1.98, 95%CI (1.31,2.99)], but was not effective in HBeAg seroconversion.      拉米夫定25mg/d的HBV-DNA转阴率高于对照组[97·9%vs22·2%,RR=4·41,95%CI(2·86,6·79)]; 组织学反应率高于对照组[59·3%vs30%,RR=1·98,95%CI(1·31,2·99)],但HBeAg血清转换与对照组相比,差异无统计学意义。 短句来源      HBeAg seroconversion of genotype B was 11.65%, of genotype C was 20.64%, and of coinfection of genotype B and C was 18.57%(P>0.05).      HBeAg血清转换率:B型11.65%,C型20.64%,BC混合型18.57%,三者比较,差异无统计学意义; 短句来源      For HBeAg seroconversion,these figures were 17.4%,22.2%, and 33.3% respectively.      HBeAg血清转换率分别为 17 4 % ,2 2 2 % ,33 3%。 短句来源      HBeAg loss rate and HBeAg seroconversion rate at 52 week in group PAA were 200% and 17% compared with 13% and 8% in group AAA.      PAA 组和 AAA 组 HBeAg 转阴率分别为20%(24/119)和13%(30/237),血清转换率分别为17%(20/116)和8%(19/232). 短句来源 更多          “血清转换”译为未确定词的双语例句      the rate of HBeAg/HBeAb seroconversion was 5.2%、9.9%、12.5%、16.4%;      HBeAg /抗HBe血清转换率分别为 5 .2 %、9.9%、12 .5 %、16.4% ; 短句来源      Results After the treatment 52 weeks,the blood serum transformation rate of LAM+Tα1 treatment group is 61.3%(19/31),significantly higher than that of the LAM group 20.5%(7/34) obviously, P<0.05;      结果治疗52周时LAM+Tα1组HBeAg血清转换率61.3%(19/31)明显高于LAM组20.5%(7/34),P<0.05; 短句来源      HBeAg/Anti-HBe seroconversion rates achieved52.00%,45.00%in joining group and LAM group.      HBeAg/抗HBe血清转换率联合组为52.00 % ,LAM组为45.00 %。 短句来源      HBeAg/Anti-HBe seroconversion rates achieved44.00%,14.00%in joining group and LAMgroup.      HBeAg/抗HBe血清转换率 ,联合治疗组为44.00 % ,LAM组为14.00 %。 短句来源      Results After treatmented for 12 months with lamivudine the negative conversion rate of serum HBV-DNA,the negative conversion rate of HBeAg,the seroconversion rate of HBeAg/HBeAb and normalization rate of ALT were 71.88%(23/32),25.93%(7/27),18.52%(5/27),62.50%(20/32) respectively.      结果拉米夫定治疗12个月,HBV-DNA转阴率71.88%(23/32),HBeAg转阴率25.93%(7/27),HBeAg/HBeAb血清转换率18.52%(5/27),ALT复常率62.50%(20/32); 短句来源 更多        查询“血清转换”译词为用户自定义的双语例句     我想查看译文中含有：的双语例句 为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法，我们为您准备了出自英文原文的大量英语例句，供您参考。   serum conversion The serum conversion incidence of each infectious agent was determined by testing 2 blood samples, collected in 1985 and in 1987. 例句来源       Serum conversion against NS1 was first detected 10 days after infection and NS1-specific antibodies were detectable up to half a year post infection. 例句来源       Furthermore, it could be noted that the survival rate was high in groups in which the serum conversion rate was high, irrespective of the thymectomy at birth. 例句来源       Serum conversion against 3ABC was first detected 8 days post-infection and demonstrable levels of 3ABC specific antibodies were detectable at least 1 year post-infection. 例句来源       However, while serum conversion indicates a systemic release of SAgs during infection, it allows no conclusions about the SAg effects on T cells. 例句来源       更多             hbeag seroconversion Acute hepatitis C virus superinfection followed by spontaneous HBeAg seroconversion and HBsAg elimination 例句来源       Lamivudine achieves HBeAg seroconversion in 15% to 20% of patients treated for 12 months, but (HBsAg) loss is rare. 例句来源       Adefovir achieves HBeAg seroconversion in 12% of patients treated for 12 months, but HBsAg loss is rare. 例句来源       All patients who maintained viral replication showed generalized nuclear reactivity for HBcAg on presentation; such reactivity was also found in 16 of 31 (52%) patients who reached anti-HBeAg seroconversion. 例句来源       HBeAg seroconversion was observed in 5 (33%) of the retreated children and in 5 (26%) of the control patients during follow up. 例句来源       更多             serological conversion The serological conversion rate following vaccination of the infants exhibiting transplacental maternal antibody was as low as 38%, in contrast with 100% sero-conversion of the infants without measurable antibodies of maternal origin. 例句来源       Six weeks later a repeat Gd-DOTA CV-MRI showed an almost complete resolution of the areas of hyperenhancement and there was a significant reduction in the adenovirus antibody titer with serological conversion to IgG. 例句来源                Out of 748 persons on a farm, 147 saympto-             作者等从748人中检出147名HBsAg无症状携带者,进行了动态观察。HBsAg阳性率19.65%,抗-HBs阳性率30.75%,抗-HBc阳性率23.62%。儿童携带率低,HBsAg滴度亦低,2~6以下占77.92%,半年内转阴率71.93%。观察过程中发现HBsAg·Ab有血清转换和滴度变化。HBsAg滴度2~8以上时,HBeAg及Dane颗粒检出率高。密切接触可能是家庭内感染的主要途径。 文摘来源          A follow-up study on HBeAg and Anti-HBe system was carried out among 310 HBsAg             对310例HBsAg携带者的e系统经2.5～6年(平均4.2年)的追踪观察结果表明,85例e 抗原阳性者中66人阴转(占77.6%),平均每年自然阴转率为18.5%,其中从e 抗原向e 抗体的血清转换占20%。44例e 抗体阳性者中有52.3%的人阴转,有1例(占2.3%)向e 抗原逆转,同时肝炎急性发作。181例e 系统阴性者有86.2%仍阴性,11.6%出现抗体。e 抗原阴阳交迭现象,在e 抗原阳性者中占18.8%(16/85),在e 系统阴性者中占7.7%(14/181),两者有非常显著性差别。影响e 抗原阴转的因素有时间,性别与HBsAg 滴度。 文摘来源          Infection rate of HBV in the high-risk population, such as dentists and the patients undertaking hemodialysis, was not higher than those in general population. The occurrence of the subclinical infection state might be resulted from hypo-responsiveness of humoral and cellular immunity to HBsAg. Of 257 cases of liver biopsy, 44% of them were diagnosed as chronic hepatitis of various categories. No relationship was found between the expression patterns of viral antigens and the inflammatory activity in the li...             综合报道近年来作者等对慢性HBV无症状感染的研究结果。处于受“高威胁”的口腔科医务人员和血液透析病人的HBV感染率并不高于一般人群。无症状感染状态的存在,是由于对HBsAg的体液和细胞免疫功能不全。经肝活检的257例,44％诊断为不同类型的慢性肝炎。在肝组织病毒抗原的表型与肝内炎症活动性之间,未发现有明显相关性。感染状态相当稳定。HBeAg/抗-HBe血清转换不是病毒复制与非复制时相的截然转折点。肝内有整合型病毒核酸的个例,可以是血清病毒抗原阴性的基因组携带者。上述结果构成我国“高发地区低反应型”HBV感染的特点。 文摘来源   << 更多相关文摘         相关查询: 血清转换率 hbeag血清转换 （血清 血清血管紧张素转换酶 转换 (血清 血清 hbeag血清转换率 转换滤光片 视域转换 转换解释器 转换轮廓  对查询结果不满意

CNKI小工具 在Springer中查有关的英文论文 在知识搜索中查有关血清转换的内容 在数字搜索中查有关血清转换的内容 在概念知识元中查有关血清转换的内容 在学术趋势中查有关血清转换 的内容

CNKI主页 |  设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务

2008 CNKI－中国知网

京ICP证040431号 互联网出版许可证 新出网证(京)字008号 北京市公安局海淀分局 备案号：110 1081725  2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社